Recent xenograft studies have shown that plerixafor-mobilized HSPCs from patients with SCA, when transplanted into immunodeficient mice, exhibit enhanced differentiation toward the myeloid lineage and generate more CD14+ cells compared to those from HDs 19. This evidence concerns the gene CD14 and autosomal dominant cerebellar ataxia.